Efficacy and Safety of DTG/3TC in Treatment-naïve HIV-1 Infected Patients

Chungnam National University Hospital

Status: Invitation-only

Conditions: HIV

Treatments: Drug: DTG + 3TC FDC

Study type: Observational

Funder types: Other

Identifiers

NCT06928090

CNUH 2024-10-046

Details and patient eligibility

About

Non-interventional, retrospective, single arm study of individuals who have initiated a DTG/3TC regimen. Medical chart will be reviewed by the investigators. Naive subjects will be identified by the clinic database as having initiated DTG/3TC.

Enrollment: 200 estimated patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• HIV-1 diagnosis
• Prescribed DTG/3TC alone to manage HIV-1 infection as initial antiretroviral treatment at the study centers

Exclusion criteria

• HIV-2 diagnosis
• Previous antiretroviral treatment

Trial design

200 participants in 1 patient group

DTG/3TC

Description:

Single arm cohort

Treatment:

Drug: DTG + 3TC FDC